Neomycin is an aminoglycoside antibiotic discovered in 1949. It belongs to a class of antibiotics containing two or more aminosugars bonded together. Neomycin is commonly used topically in creams and eyedrops but can also be taken orally combined with other antibiotics. It works by binding to the 30S subunit of the ribosome to inhibit protein translation from mRNA. However, neomycin can cause ototoxicity and hearing loss.